← Leaderboards
Jamal A Ibdah
Harry S. Truman Memorial Va Hospital
$4,036,560
Attributed
$6,471,496
Total exposure
9
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $878.9K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,691,996 · 8
VA$0 · 2
By mechanism
R01$5,963,915 · 3
P20$441,000 · 2
K08$240,840 · 1
M01$46,241 · 2
I01$0 · 2
Top collaborators
- Elizabeth Jane Parks6 shared
- Randy Scott Rector6 shared
Others in their field
Top investigators on “Gene Expression”
- Jeffrey P Krischer · University Of South Florida$137,481,663
- Eric S Lander · Whitehead Institute For Biomedical Res$128,154,716
- Stacey Gabriel · Massachusetts Institute Of Technology$86,302,566
- Bruce W Stillman · Cold Spring Harbor Laboratory$82,324,317
- Michael P Snyder · Yale University$75,701,723
- Ronald G Crystal · Weill Medical College Of Cornell Univ$74,774,977
Research focus
Gene ExpressionLong Chain Fatty AcidOxidationMitochondriaMeasurementFatty Acid OxidationNonalcoholic SteatohepatitisLiverObesityFibrosisHuman DataHistologicAnimalsLinkPrevalenceImaging StudyPrimary Malignant Neoplasm Of LiverIn VitroFatty AcidsLiver MitochondriaPathologicLaboratory MouseGene MutationNon-Alcoholic Fatty Liver Disease
Grant awards (32)
Low Dose Thyroid Hormone, Mitochondrial Fatty Acid Oxidation, and Treatment of Nonalcoholic Steatohepatitis (NASH)$0
I01 · FY2025 · VA · contact PI
Low Dose Thyroid Hormone, Mitochondrial Fatty Acid Oxidation, and Treatment of Nonalcoholic Steatohepatitis (NASH)$0
I01 · FY2024 · VA · contact PI
Role of non-genomic regulation of mitochondrial trifunctional protein in NAFLD$0
I01 · FY2023 · VA · contact PI
Low Dose Thyroid Hormone, Mitochondrial Fatty Acid Oxidation, and Treatment of Nonalcoholic Steatohepatitis (NASH)$0
I01 · FY2023 · VA · contact PI
Role of non-genomic regulation of mitochondrial trifunctional protein in NAFLD$0
I01 · FY2022 · VA · contact PI
Nutrient Overload, Insulin Resistance, and Hepatic Mitochondrial Dysfunction$690,058
R01 · FY2021 · DK
Nutrient Overload, Insulin Resistance, and Hepatic Mitochondrial Dysfunction$188,834
R01 · FY2021 · DK
Role of non-genomic regulation of mitochondrial trifunctional protein in NAFLD$0
I01 · FY2021 · VA · contact PI
Nutrient Overload, Insulin Resistance, and Hepatic Mitochondrial Dysfunction$692,311
R01 · FY2020 · DK
Role of non-genomic regulation of mitochondrial trifunctional protein in NAFLD$0
I01 · FY2020 · VA · contact PI
Nutrient Overload, Insulin Resistance, and Hepatic Mitochondrial Dysfunction$689,516
R01 · FY2019 · DK
Nutrient overload, insulin resistance, and hepatic mitochondrial dysfunction$694,416
R01 · FY2018 · DK
Nutrient overload, insulin resistance, and hepatic mitochondrial dysfunction$697,269
R01 · FY2017 · DK
Beta-Oxidation and Susceptibility to Fatty Liver Disease$262,473
R01 · FY2008 · DK · contact PI
Beta-Oxidation and Susceptibility to Fatty Liver Disease$267,829
R01 · FY2007 · DK · contact PI
Beta-Oxidation and Susceptibility to Fatty Liver Disease$275,828
R01 · FY2006 · DK · contact PI
CTSA PLANNING PROJECT: MU INSTITUTE FOR CLINICAL AND TRANSLATIONAL SCIENCE$220,500
P20 · FY2006 · RR · contact PI
CTSA Planning Project:MU Institute for Clinical$220,500
P20 · FY2006 · RR · contact PI
Maternal Liver Disease and Fatty Acid Oxidation Defects$279,300
R01 · FY2005 · DK
Maternal Liver Disease and Fatty Acid Oxidation Defects$38,205
R01 · FY2005 · DK
LIVER DISEASE AND FATTY OXIDATION DISORDERS$847
M01 · FY2005 · RR
Maternal Liver Disease and Fatty Acid Oxidation Defects$273,600
R01 · FY2004 · DK
Maternal Liver Disease and Fatty Acid Oxidation Defects$35,818
R01 · FY2004 · DK
Liver Disease and Fatty Oxidation Disorders$21,162
M01 · FY2004 · RR
Maternal Liver Disease and Fatty Acid Oxidation Defects$273,600
R01 · FY2003 · DK
Maternal Liver Disease and Fatty Acid Oxidation Defects$34,439
R01 · FY2003 · DK
Maternal Liver Disease and Fatty Acid Oxidation Defects$32,976
R01 · FY2003 · DK
Maternal Liver Disease and Fatty Acid Oxidation Defects$273,600
R01 · FY2002 · DK
Maternal Liver Disease and Fatty Acid Oxidation Defects$263,843
R01 · FY2001 · DK
MOLECULAR ANALYSIS OF FATTY ACID OXIDATION DEFECT$120,420
K08 · FY2001 · DK
MOLECULAR ANALYSIS OF FATTY ACID OXIDATION DEFECT$120,420
K08 · FY2000 · DK
EFFECTS OF HIGH FAT DIET ON HETEROZYGOTES W/ MUTATIONS IN FATTY ACID$24,232
M01 · FY2000 · RR